Literature DB >> 29054585

[Influence of epigenetic in Sjögren's syndrome].

A Bordron1, A Charras1, C Le Dantec1, Y Renaudineau2.   

Abstract

Sjögren's syndrome (SS) is a systemic autoimmune epithelitis with a major female incidence, and characterized by a dry syndrome, impaired quality of life, visceral involvement, and lymphoma for the most aggressive cases. During this process, epithelial cells acquire the capacity to produce cytokines, chemokines, and autoantigens which can in turn be presented to the immune system. Consequently, this epithelitis is accompanied by lymphocytic infiltrations leading to the formation of pseudo-follicles in which self-reactive B lymphocytes are present. The recent integration of genomic and especially of epigenomic data, which make it possible to analyze the different cellular partners, opens new perspectives and allows to a better understanding of this complex and still incurable disease.
Copyright © 2017 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Autoimmune disease; B lymphocytes; Dry syndrome; Epigenetic; Lymphocytes B; Maladie auto-immune; Sjögren's syndrome; Syndrome de Gougerot-Sjögren; Syndrome sec; Épigénétique

Mesh:

Year:  2017        PMID: 29054585     DOI: 10.1016/j.revmed.2017.09.003

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

Review 1.  JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren's Syndrome.

Authors:  Amandine Charras; Pinelopi Arvaniti; Christelle Le Dantec; Marina I Arleevskaya; Kaliopi Zachou; George N Dalekos; Anne Bordon; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

Review 2.  Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis.

Authors:  Pinelopi Arvaniti; Kalliopi Zachou; Aggeliki Lyberopoulou; Nikolaos K Gatselis; Wesley H Brooks; George N Dalekos; Yves Renaudineau
Journal:  Epigenomes       Date:  2019-08-08

3.  JAK Inhibitors and Oxidative Stress Control.

Authors:  Amandine Charras; Pinelopi Arvaniti; Christelle Le Dantec; George N Dalekos; Kaliopi Zachou; Anne Bordron; Yves Renaudineau
Journal:  Front Immunol       Date:  2019-12-06       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.